Evidence map›Paper›PMID 33590280›Full record

ArticleWorld journal of urology2021

Initial clinical experience with the new thulium fiber laser: first 50 cases.

Mariela Corrales, Olivier Traxer

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Adoption of thulium fiber laser for lithotripsy A scoping review and bibliometric analysis.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Observational
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mariela CorralesSorbonne University GRC Urolithiasis No. 20 Tenon Hospital, 75020, Paris, France.
Olivier TraxerSorbonne University GRC Urolithiasis No. 20 Tenon Hospital, 75020, Paris, France. olivier.traxer@aphp.fr.ORCID http://orcid.org/0000-0002-2459-3803

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the efficacy, safety, and laser settings of thulium fiber laser (TFL) in laser lithotripsy during retrograde intrarenal surgery (RIRS) for ureteral and renal stones.

methodsA prospective study of the first 50 patients with ureteral and renal stones who underwent RIRS using TFL (SOLTIVE Premium, Olympus, Japan) was performed. 200 and 150 µm laser fibers were used for ureteral and renal stones, respectively. Stone size, stone density, laser-on time (LOT), and laser settings were recorded. We also assessed the ablation speed (mm

resultsA total of 50 patients were included in the study with a median (IQR) age of 66 (55.5-74) years old for patients with ureteral stones and 55 (44-61.5) years old for patients with renal stones. Most of the patients had a Charlson comorbidity index score of 0. Median (IQR) stone volume for ureteral stones was 486 (332-1250) mm

conclusionTFL is a safe and effective modality for lithotripsy during RIRS with minimal complication rates.

Indexed as

ThuliumAgedFemaleHumansKidney CalculiLithotripsy, LaserMaleMiddle AgedProspective StudiesUreteral CalculiThuliumKidneyRIRSThulium fiber laserUreterUrinary stonesUrolithiasis

Identifiers

PMID33590280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.